Progyny, Inc.
Health
Performance
7.3
Risk
Sell
Buy
Curious about the Scores? Learn more.

Progyny, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

31.07.2026
On shaky ground. Struggling to find a clear direction.
19.05.2026
Slight bounce. Could be noise – or a comeback brewing.
09.05.2026
Off life support. Still risky, but slightly less scary.
20.08.2025
Health’s picking up. Numbers look cleaner, cash flow tighter.
PGNY
Progyny, Inc.
25.94
-14.13%
7.3
Sell
Buy
Progyny, Inc.

Progyny, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Progyny, Inc. do? Business model and key facts

Get the full picture of Progyny, Inc.: what it builds, where it operates, and how it makes money.

Progyny, Inc. Profile

Sector: Healthcare

Industry: Medical - Healthcare Information Services

Employees (FY): 856

Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.

shop
Company facts
Pete Anevski
CEO
856
Employees worldwide
shop
Performance
28.61%
Last 12 months
-37.4%
Last 5 years
shop
Growth
$1.29B
Revenue year
$58.52M
Net income
shop
Valuation
$2.44B
Market Cap
37.76
Price/Earnings Ratio

Stocks related to Progyny, Inc.

Selected based on industry alignment and relative market positioning.

PRVA
Privia Health Group, Inc.
22.26
+1.18%
5.3
Sell
Buy
Privia Health Group, Inc.
DOCS
Doximity, Inc.
20.66
-4.48%
7.6
Sell
Buy
Doximity, Inc.
WAY
Waystar Holding Corp.
24.23
+3.68%
6.2
Sell
Buy
Waystar Holding Corp.
WGS
GeneDx Holdings Corp.
69.61
+0.03%
8.9
Sell
Buy
GeneDx Holdings Corp.
CERT
Certara, Inc.
8.16
+0.37%
8.8
Sell
Buy
Certara, Inc.

Events and news impacting Progyny, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Progyny, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.